Marinus Pharmaceuticals

-$1.24 (-8.24%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRNS and other ETFs, options, and stocks.

About MRNS

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.

CEO
Scott N. Braunstein
Employees
72
Headquarters
Radnor, Pennsylvania
Founded
2003

MRNS Key Statistics

Market Cap
616.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
137.30K
High Today
$15.63
Low Today
$13.74
Open Price
$15.52
Volume
319.11K
52 Week High
$20.04
52 Week Low
$6.56

MRNS Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure